Tuberculosis Clinical Trial
— TBTechOfficial title:
Does Providing Medical Personnel in the AMPATH Network With Patient-specific Reminders Regarding TB That Are Generated From a Patient's EMR Improve the Prevalence of IPT Initiation and Decrease the Time From Screening to Treatment?
Verified date | March 2023 |
Source | Indiana University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The overall research objective is to evaluate the impact of implementing a reminder system for medical providers to improve TB case-finding and isoniazid preventative therapy (IPT) for adults living with HIV in western Kenya
Status | Completed |
Enrollment | 3782 |
Est. completion date | August 2014 |
Est. primary completion date | August 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 16 Years and older |
Eligibility | Clusters: Inclusion Criteria - active - uses HIV initial and return encounter paper forms - enters data into the AMPATH medical records system (AMRS) or sends forms to central location for data entry - prints or receives printed paper summary sheets with reminders - interprets chest x-rays - interprets sputum smear results - prescribes IPT and dispenses INH - completed an average of 10 initial adult HIV positive encounters per month in 2012 - HIV Care Clinic Exclusion Criteria - Patients: Inclusion Criteria - HIV positive - complete an adult initial encounter at an HIV Care Clinic during the enrollment period - attend at least one additional appointment within 90 days after the initial encounter Exclusion Criteria - history of TB or IPT |
Country | Name | City | State |
---|---|---|---|
Kenya | AMPATH | Eldoret |
Lead Sponsor | Collaborator |
---|---|
Indiana University | Academic Model Providing Access to Healthcare (AMPATH), Innovative Support to Emergencies, Diseases and Disasters (InSTEDD), Kijani Consulting, Moi University, Regenstrief Institute, Inc. |
Kenya,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Initiation of isoniazid prophylactic therapy (IPT) | IPT will be considered "initiated" when a patient picks up the initial batch of the prescribed medications within 3 months of the initial encounter. | within 3 months of initial encounter | |
Other | Isoniazid prophylactic therapy (IPT) completion | Patient completes 9-month course of IPT | 9 months after treatment initiation | |
Primary | Prescription of Isoniazid | Provider prescribes INH within 3 months of patient's initial encounter. | within 3 months of initial encounter | |
Secondary | Time to isoniazid prophylactic therapy (IPT) initiation | The time in weeks from a patient's initial encounter to the week the patient picks up the initial batch of INH from the pharmacy. | within 3 months of initial encounter |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05738681 -
Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial
|
Phase 2/Phase 3 | |
Recruiting |
NCT05526885 -
Tuberculosis Diagnostic Trial of CAD4TB Screening Alone Compared to CAD4TB Screening Combined With a CRP Triage Test, Both Followed by Confirmatory Xpert MTB/RIF Ultra in Communities of Lesotho and South Africa
|
N/A | |
Completed |
NCT04369326 -
Community Initiated Preventive Therapy for TB
|
N/A | |
Recruiting |
NCT04568967 -
TB-CAPT EXULTANT - HIV
|
N/A | |
Completed |
NCT02337270 -
Phase 1 Clinical Trial of the Safety and Immunogenicity of an Adenovirus-based TB Vaccine Administered by Aerosol
|
Phase 1 | |
Not yet recruiting |
NCT06253715 -
Shortened Regimen for Drug-susceptible TB in Children
|
Phase 3 | |
Recruiting |
NCT04271397 -
Immunological Biomarkers in Tuberculosis Management
|
N/A | |
Withdrawn |
NCT03639038 -
Tuberculosis Diagnosis by Flow Cytometry
|
||
Completed |
NCT03199313 -
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid
|
Phase 1 | |
Recruiting |
NCT04975178 -
Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
|
Phase 3 | |
Completed |
NCT04463680 -
Rifampin and the Contraceptive Implant
|
Phase 4 | |
Completed |
NCT03973970 -
Assessing the Ability of the T-SPOT®.TB Test (IQ)
|
||
Recruiting |
NCT04230395 -
Alcohol Reduction Among People With TB and HIV in India
|
N/A | |
Completed |
NCT04874948 -
Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment
|
Phase 1 | |
Active, not recruiting |
NCT02906007 -
Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIV
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05917210 -
Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda
|
N/A | |
Not yet recruiting |
NCT06017843 -
Impact Evaluation of Use of MATCH AI Predictive Modelling for Identification of Hotspots for TB Active Case Finding
|
N/A | |
Not yet recruiting |
NCT05845112 -
Start Taking Action For TB Diagnosis
|
||
Active, not recruiting |
NCT02715271 -
Study of TB Lesions Obtained in Therapeutical Surgery
|
||
Completed |
NCT02781909 -
Potential Efficacy and Safety of Using Adjunctive Ibuprofen for XDR-TB Tuberculosis
|
Phase 2 |